MedPath

Therapeutic effect of the regiment of helicobacter pylori treatment on the improvement of pain and symptoms of arthritis in patients with rheumatoid arthritis

Phase 3
Conditions
Rheumatoid arthritis.
Rheumatoid arthritis with rheumatoid factor
Registration Number
IRCT20231209060313N1
Lead Sponsor
Shahre-kord University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
60
Inclusion Criteria

Age over 18 years
Patients with mild to moderate rheumatoid arthritis diagnosed by EULAR criteria (under traditional treatment with DMARD)
Willingness to participate in the clinical trial
Presence of positive H pylori infection based on endoscopy, fecal antigen or serum antibody test
No recent use of antibiotics
Absence of immunodeficiency diseases and active cancer
Having an indication for the treatment of Helicobacter pylori infection

Exclusion Criteria

The patient's unwillingness to participate in the clinical trial
death of the patient
Severe rheumatoid arthritis and the use of biological drugs in the treatment of RA
Patients with other systemic diseases, who have gastrointestinal surgery, have an active gastric ulcer, or synovectomy in any major joint.
pregnancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath